Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Senior Director of Marketing & Communications:
Lauren Grella

Email: media@path.org

Recent Press Coverage

  1. The Seattle-based global health nonprofit is deploying large-language model (LLM) technology at clinics in Nairobi to analyze patient symptoms, health histories, provider notes and lab results, and then assist with diagnosis and treatment planning.
    Published: July 2025
  2. GeekWire's Lisa Stiffler attended the ribbon cutting ceremony for PATH's new Seattle office, toured PATH's engineering and biosafety labs, and spoke with experts and leaders.
    Published: June 2025
  3. PATH’s Nikolaj Gilbert and Dame Sally Davies write in The Telegraph about drug-resistant infections that are outpacing our ability to treat them—and how the global community must come together to address this growing global threat.
    Published: March 2025
  4. PATH is among the global partners receiving funding from the GHIT Fund’s $12.7 million investment to advance new diagnostics and drug development for malaria and neglected tropical diseases (NTDs).
    Published: January 2025

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

Related articles

Read our latest

995 Item s
995 Item s
    Date
    From
    To
  1. During the Union World Conference on Lung Health 2026, PATH will highlight our work advancing innovations for integrated, people-centered tuberculosis care.
    Published: November 2026
    Announcement
  2. With support from the GHIT Fund, the partners will develop a tool to enable early NiV and HeV outbreak detection in rural and low-resource settings, reducing transmission and saving lives.
    Published: October 2026
    Press Release
  3. GHIT Fundの支援のもと、医療資源の限られた地域においてニパウイルス(NiV)およびヘンドラウイルス(HeV)の流行を早期に検出できるツールを開発し、感染拡大の抑制と人命の保護を目指します
    Published: October 2026
    Press Release
  4. PATH’s Sustaining Vaccine Manufacturing program supported Bio Farma in reaching this crucial milestone, which can expand rotavirus protection for young children across Indonesia.
    Published: October 2026
    Announcement
  5. How did an ambitious idea become one of the most consequential global health commitments in history? And what will it take to sustain that kind of commitment today?
    Published: October 2026
    Announcement